Objective To explore the effect of concentrated growth factor(CGF)combined with autologous fat transplantation in augmentation mammoplasty.Methods Clinical data of 28 female patients who underwent autologous fat by CG...Objective To explore the effect of concentrated growth factor(CGF)combined with autologous fat transplantation in augmentation mammoplasty.Methods Clinical data of 28 female patients who underwent autologous fat by CGF mixed with purified fat between May 2015 and June 2018 were retrospectively analyzed.Clinical evaluation was performed to observe and measure the shape of the breast after breast augmentation,the increase in the value of the nipple plane measurement,and complications.Results All of 28 patients,after 12 months of follow-up,all patients no fat infection,hematoma,breast nodules and other complications.It showed that the contouring of breast were improved and more chubbiness than that before operation.The results were satisfied from patients.Conclusion Concentrated growth factor combined with autologous fat transplantation has a stable breast augmentation effect,beautiful breast shape,simple operation and small damage,which achieves breast rejuvenation.展开更多
目的:探讨浓缩生长因子纤维蛋白膜联合Bio-Oss骨粉修复拔牙术后牙槽骨缺损的疗效。方法:选择2018年1月-2020年1月笔者医院收治的因拔除下颌阻生第三磨牙致第二磨牙远中骨缺损患者76例,予以随机数字表法分为对照组(Bio-Oss骨粉植入,38例...目的:探讨浓缩生长因子纤维蛋白膜联合Bio-Oss骨粉修复拔牙术后牙槽骨缺损的疗效。方法:选择2018年1月-2020年1月笔者医院收治的因拔除下颌阻生第三磨牙致第二磨牙远中骨缺损患者76例,予以随机数字表法分为对照组(Bio-Oss骨粉植入,38例)和观察组(CGF膜联合Bio-Oss骨粉植入,38例)。手术后3 d复诊观察患者术后疼痛、开口度情况,比较两组患者术后1周创面愈合情况以及术前、术后1个月和3个月牙槽骨密度、牙槽嵴高度及牙槽嵴宽度,记录术后不良反应。结果:对照组术后3 d VAS评分(3.35±0.47)分,观察组为(2.67±0.42)分,对照组开口度(2.75±0.46)cm,观察组(2.68±0.51)cm,两组比较差异均无统计学意义(P>0.05)。术后1周,观察组创面愈合情况好于对照组,差异有统计学意义(P<0.05);术后1个月、术后3个月,观察组牙槽骨密度、牙槽嵴高度、牙槽嵴宽度均高于对照组,差异有统计学意义(P<0.05)。对照组术后不良反应发生率23.68%,高于观察组的5.26%,差异有统计学意义(P<0.05)。结论:浓缩生长因子纤维蛋白膜联合Bio-Oss骨粉在第二磨牙远中骨缺损修复中发挥着重要作用,值得临床推广应用。展开更多
背景:牙列缺损患者缺牙区的软硬组织不足是影响口腔种植治疗效果的重要因素,在拔牙后或种植体植入期间使用血小板浓缩物进行辅助治疗有望解决这一难题,改善口腔种植疗效。目的:本研究旨在通过检索近10年发表的有关血小板浓缩物在种植领...背景:牙列缺损患者缺牙区的软硬组织不足是影响口腔种植治疗效果的重要因素,在拔牙后或种植体植入期间使用血小板浓缩物进行辅助治疗有望解决这一难题,改善口腔种植疗效。目的:本研究旨在通过检索近10年发表的有关血小板浓缩物在种植领域应用的文献,总结目前文献研究中的详细情况及研究热点,进而探索该领域研究的流行趋势,为该领域未来研究及发展方向提供指引和参考。方法:在Web of Science数据库核心合集中检索在2012-2021年间发表的有关血小板浓缩物在口腔种植领域应用的文献,将检出文献进行去重及筛选后,使用Citespace 5.8 R3软件对筛选后的文献进行关键词与文献共被引等情况的分析,并将分析结果进行可视化展示。结果与结论:本研究共纳入有效文献328篇。2012-2021年间,血小板浓缩物在口腔种植领域应用的文献数量在前期呈略微上升,而在后期趋于平稳。在本研究纳入的文献中,通过对关键词的使用频次分析、关键词的聚类分析以及高被引文献的分析可知,在2012-2021年间,该领域的研究中血小板浓缩物与“自体骨”的临床疗效受到了学界的较多关注;同时,血小板浓缩物中富含的多种“生长因子”的相关文章也逐年增加。在口腔种植相关研究中,组织工程常用种子细胞“间充质干细胞”、临床种植骨量不足的常用材料“膜”及常用增骨术式“上颌窦提升术”均与血小板浓缩物存在一定的研究热度。展开更多
Knees are the most commonly impacted weight-bearing joints in osteoarthritis(OA),affecting millions of people worldwide.With increasing life spans and obesity rates,the incidence of knee OA will further increase,leadi...Knees are the most commonly impacted weight-bearing joints in osteoarthritis(OA),affecting millions of people worldwide.With increasing life spans and obesity rates,the incidence of knee OA will further increase,leading to a significant increase in the economic burden.Conventional treatment modalities utilized to manage knee OA have limitations.Over the last decade,the role of various autologous peripheral blood-derived orthobiologics(APBOs)for the treatment of knee OA has been extensively investigated.This editorial provided an overview and focused on defining and shedding light on the current state of evidence based on the most recent published clinical studies concerning the use of APBO for the management of knee OA.While numerous studies have demonstrated promising results for these preparations,a notable gap exists in the comparative analysis of these diverse formulations.This absence of head-to-head studies poses a considerable challenge for physicians/surgeons in determining the optimal preparation for managing knee OA and achieving sustained longterm results.Thus,more adequately powered,multicenter,prospective,doubleblind,randomized controlled trials with longer follow-ups are needed to establish the long-term efficacy and to aid physicians/surgeons in determining the optimal APBO for the management of knee OA.展开更多
文摘Objective To explore the effect of concentrated growth factor(CGF)combined with autologous fat transplantation in augmentation mammoplasty.Methods Clinical data of 28 female patients who underwent autologous fat by CGF mixed with purified fat between May 2015 and June 2018 were retrospectively analyzed.Clinical evaluation was performed to observe and measure the shape of the breast after breast augmentation,the increase in the value of the nipple plane measurement,and complications.Results All of 28 patients,after 12 months of follow-up,all patients no fat infection,hematoma,breast nodules and other complications.It showed that the contouring of breast were improved and more chubbiness than that before operation.The results were satisfied from patients.Conclusion Concentrated growth factor combined with autologous fat transplantation has a stable breast augmentation effect,beautiful breast shape,simple operation and small damage,which achieves breast rejuvenation.
文摘目的:探讨浓缩生长因子纤维蛋白膜联合Bio-Oss骨粉修复拔牙术后牙槽骨缺损的疗效。方法:选择2018年1月-2020年1月笔者医院收治的因拔除下颌阻生第三磨牙致第二磨牙远中骨缺损患者76例,予以随机数字表法分为对照组(Bio-Oss骨粉植入,38例)和观察组(CGF膜联合Bio-Oss骨粉植入,38例)。手术后3 d复诊观察患者术后疼痛、开口度情况,比较两组患者术后1周创面愈合情况以及术前、术后1个月和3个月牙槽骨密度、牙槽嵴高度及牙槽嵴宽度,记录术后不良反应。结果:对照组术后3 d VAS评分(3.35±0.47)分,观察组为(2.67±0.42)分,对照组开口度(2.75±0.46)cm,观察组(2.68±0.51)cm,两组比较差异均无统计学意义(P>0.05)。术后1周,观察组创面愈合情况好于对照组,差异有统计学意义(P<0.05);术后1个月、术后3个月,观察组牙槽骨密度、牙槽嵴高度、牙槽嵴宽度均高于对照组,差异有统计学意义(P<0.05)。对照组术后不良反应发生率23.68%,高于观察组的5.26%,差异有统计学意义(P<0.05)。结论:浓缩生长因子纤维蛋白膜联合Bio-Oss骨粉在第二磨牙远中骨缺损修复中发挥着重要作用,值得临床推广应用。
文摘背景:牙列缺损患者缺牙区的软硬组织不足是影响口腔种植治疗效果的重要因素,在拔牙后或种植体植入期间使用血小板浓缩物进行辅助治疗有望解决这一难题,改善口腔种植疗效。目的:本研究旨在通过检索近10年发表的有关血小板浓缩物在种植领域应用的文献,总结目前文献研究中的详细情况及研究热点,进而探索该领域研究的流行趋势,为该领域未来研究及发展方向提供指引和参考。方法:在Web of Science数据库核心合集中检索在2012-2021年间发表的有关血小板浓缩物在口腔种植领域应用的文献,将检出文献进行去重及筛选后,使用Citespace 5.8 R3软件对筛选后的文献进行关键词与文献共被引等情况的分析,并将分析结果进行可视化展示。结果与结论:本研究共纳入有效文献328篇。2012-2021年间,血小板浓缩物在口腔种植领域应用的文献数量在前期呈略微上升,而在后期趋于平稳。在本研究纳入的文献中,通过对关键词的使用频次分析、关键词的聚类分析以及高被引文献的分析可知,在2012-2021年间,该领域的研究中血小板浓缩物与“自体骨”的临床疗效受到了学界的较多关注;同时,血小板浓缩物中富含的多种“生长因子”的相关文章也逐年增加。在口腔种植相关研究中,组织工程常用种子细胞“间充质干细胞”、临床种植骨量不足的常用材料“膜”及常用增骨术式“上颌窦提升术”均与血小板浓缩物存在一定的研究热度。
文摘Knees are the most commonly impacted weight-bearing joints in osteoarthritis(OA),affecting millions of people worldwide.With increasing life spans and obesity rates,the incidence of knee OA will further increase,leading to a significant increase in the economic burden.Conventional treatment modalities utilized to manage knee OA have limitations.Over the last decade,the role of various autologous peripheral blood-derived orthobiologics(APBOs)for the treatment of knee OA has been extensively investigated.This editorial provided an overview and focused on defining and shedding light on the current state of evidence based on the most recent published clinical studies concerning the use of APBO for the management of knee OA.While numerous studies have demonstrated promising results for these preparations,a notable gap exists in the comparative analysis of these diverse formulations.This absence of head-to-head studies poses a considerable challenge for physicians/surgeons in determining the optimal preparation for managing knee OA and achieving sustained longterm results.Thus,more adequately powered,multicenter,prospective,doubleblind,randomized controlled trials with longer follow-ups are needed to establish the long-term efficacy and to aid physicians/surgeons in determining the optimal APBO for the management of knee OA.
